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Abstract We use magnetic microbeads, which are mag-
netically self-assembled in chains in a microfluidic chip, as
reaction substrates to implement two different sandwich
immunoassay protocols for the detection of mouse mono-
clonal target antibodies. The magnetic chains form when the
chip is placed in a magnetic field, and are geometrically
trapped and accurately positioned in a microchannel with
periodically enlarged cross-sections. In the first immunoas-
say protocol, capture and target antibodies are incubated off-
chip, while exposure to the detection antibody is performed
on-chip. In the second protocol, the complete immunoassay
is fully executed on-chip. In the ‘off-chip incubation–on-
chip detection’ protocol, antibodies can be detected down to
a concentration of 50 ng/mL in a total assay time of 120 min,
while consuming 1.5 mL of target antibody solution. Using
the full on-chip protocol, our system is able to detect target
antibodies in the range of a few ng/mL in 30 min, using only
a few tens of nanoliters of target antibody solution and
reagents. The ‘off-chip incubation–on-chip detection’ pro-
tocol is also applied for dosing antibodies obtained from the
supernatant of a cell culture medium.
Keywords Microfluidics  Immunoassay  ELISA 
Antibody  Magnetism  Magnetic microbeads 
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1 Introduction
The miniaturization of analytical chemistry systems has
become a major challenge in the research community since
the introduction of the micro total analysis system (l-TAS)
in 1990 (Manz et al. 1990). Immunoassay analyses
(for example the Enzyme-Linked Immunosorbent Assay
(ELISA), an analytical technique widely used in clinical
diagnostics, cancer research, and food safety or environ-
mental analysis) use the sensitivity and specificity of highly
stable interactions between antigens (Ag) and their specific
antibodies (Ab). An immunoassay analysis is convention-
ally performed in microtiter plates, and consumes typically
about hundreds of lL of sample and reagent solutions, for
an assay time of hours due to mass-transport limitations. In
microfluidics, the small reaction volume and microchannel
dimensions permit a strong analysis time reduction, while
consuming minute quantities of samples and reagents
(typically a few lL). However, microfluidic integrated
systems developed for immunoassays demand additional
steps for a perfect control of microchannel surface
chemistry, to allow an efficient and reproducible Ab
immobilization. This drawback can be circumvented by
using functionalized microbeads in a fluidic chip. Micro-
beads are available at different sizes, present the advantage
of a large surface-to-volume ratio, and offer a strong flex-
ibility due to a wide range of available surface chemistries.
Their use as substrate for microfluidic immunoassays was
investigated by elaborating microbead retention strategies
at desired positions within a microchannel, using for
example a microdam (Sato et al. 2001) or micropillar cage
(Andersson et al. 2000). When microbeads incorporate
a magnetic core, they can be easily manipulated using
external magnetic fields, explaining why they are increas-
ingly used as a solid phase for Ab capture and as carriers of
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captured Ag (Gijs 2004). Their retention at the micro-
channel wall was realized using macroscopic permanent
magnets (Hayes et al. 2001), current-activated coils (Choi
et al. 2002) and wires (Siegel et al. 2006), or magnetic
structures (Deng et al. 2002; Lund-Olesen et al. 2007)
incorporated on the microchip. Mobile permanent magnets
were also used for magnetic microbeads’ manipulation in a
microfluidic chip incorporating a dual channel network, 460
nL reaction chambers and valve-activated fluidic bridges
(Herrmann et al. 2006, 2007). Recently, the manipulation
and retention of magnetic microbeads over the complete
cross-section of a microchannel was proposed using a
focused magnetic field (Rida and Gijs 2004; Slovakova
et al. 2005; Smistrup et al. 2005; Bronzeau and Pamme
2008; Peyman et al. 2008), or by trapping self-assembled
magnetic chains geometrically in a periodically structured
microchannel (Lacharme et al. 2008a, b). In these systems,
the intense liquid-magnetic microbead interactions lead to a
highly efficient active mixing or target analyte capture.
In this paper, we present and compare two protocols to
perform on-chip immunoassays using our magnetic micro-
bead retention device. The magnetic microbeads are
incubated with capture Ab (c-Ab) and target monoclonal
Ab (t-mAb) either off-chip or directly on-chip (t-mAb is
used as target antigen in our sandwich immunoassay),
while exposure to the detection Ab (d-Ab) is always
performed on-chip. The off-chip incubation–on-chip
detection protocol extends the use of our chip to magnetic
microbead-based analytical methods involving classical
bench-top Ab analysis procedures. A controlled amount of
magnetic microbeads is self-assembled in magnetic chains
that are accurately retained in the large sections of a
periodically enlarged microchannel, by simply placing the
chip in an external homogeneous magnetic field. The
self-assembled magnetic chains strongly interact with
analytes and d-Ab from the perfusing microfluidic flows.
We compare the performance of both immunoassay pro-
tocols and, as additional application example, demonstrate
the dosing of t-mAb produced by a hybridoma cell culture.
2 Microsystem design and fabrication
The schematic layout of the microchip showing the periodical
enlargement of the microchannel is presented in Fig. 1a. It
consists of a 20-lm-wide microchannel with periodical sec-
tions of 40 lm (of 5 lm length) separated by 10 lm. 130
sections of this type are realized over a total distance of 2 mm.
The microchips are microfabricated using a dry-etching
technology (Pavius 2004), to obtain a vertical microchannel
wall profile. Briefly, a 2-lm-thick layer of amorphous silicon
(a-Si) is deposited on a 4-inch Pyrex wafer, following by
spinning, exposure, and development of a positive photoresist
using a standard photolithography process. The a-Si is dry
etched using a deep reactive ion-etching (DRIE) technique,
and the remaining photoresist is stripped. Then, the Pyrex
wafer is DRIE etched to a depth of 8 lm, followed by
removal of the a-Si protective mask in a 40% KOH bath,
heated at 60C during *1 h. Finally, the wafer is cut in
individual microchips. Figure 1b shows a scanning electron
microscopy (SEM) image of the microchannel. Finally, the
microchip is loosely covered with a 2 mm thick poly-
dimethylsiloxane (PDMS) cover, which is pinched with two
access holes forming two reservoirs (reservoir A and B).
Figure 1c shows a picture of the microchip (i) on its holder
used during the experiments, where it is placed at the center
of a poly-oxymethylene support (ii), and flanked by two
permanent magnets (iii and iv) for the generation of the
permanent homogeneous magnetic field (Rida et al. 2003).
Fig. 1 a Schematic layout of the 20-lm-wide microchannel showing
the periodically enlarged sections of 40 lm. b SEM picture of
the microchannel showing the periodically varying channel width.
c Picture of the microfluidic chip in its socket. The chip consists of a
8-lm-deep plasma-etched channel in a Pyrex substrate that is sealed
with a 2.5 mm thick Polydimethylsiloxane (PDMS) cover (i). The
latter is pinched with two access holes and placed on the chip socket
(ii) that contains two permanent magnets (iii, iv) generating a
homogeneous magnetic field
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3 Magnetic bead retention principle
A solution of 500 nm diameter magnetic microbeads is
introduced into the microchannel. When a homogeneous
magnetic field is applied perpendicularly to the micro-
channel axis, the magnetic microbeads self-assemble in
magnetic chains (Doyle et al. 2002) in the microchannel’s
large cross-sections, thereby decreasing their total mag-
netic dipolar energy. Figure 2a is a schematic drawing of
the system where a flow is applied through a magnetic
chain, exerting a drag force Fdrag which displaces the
central part of the chain over a distance X. The saturation
magnetization of the microbeads is Msat = 8 9 10
4 A/m.
Then, the maximal magnetic moment of one bead
mbead = (4/3)pR
3Msat = 5.23 9 10
-15 Am2, where R is
the bead radius (250 nm). We measure with a miniaturized
Hall probe a magnetic induction of 120 mT originating
from the two permanent magnets at the center of the chip
holder, where the microchannel is inserted during experi-
ments. This magnetic induction is large enough to saturate
the magnetic moment of the microbeads. Assuming that all
the magnetic microbeads have reached their magnetic
saturation (due to the permanent magnetic field) and are
individual dipoles oriented in the external magnetic field
direction, the magnetic dipole energy of a pearl-like chain
of n microbeads is given by (Helseth 2005)
Echain ¼
Xi¼n
i¼0
Xn
j [ i
l0
4p
1
r3ij
m2bead  ð1  cos2 HijÞ ð1Þ
where l0 is the magnetic permeability of vacuum, rij the
distance between the microbeads with index i and j, and Hij
the angle between the external magnetic field direction and
the center-to-center vector of microbeads with index i and
j, respectively. When exposed to the flow, the viscous drag
force acting on the central part of 80- microbead pearl-like
magnetic chain is approximated by the Stokes drag force:
Fdrag ¼ 6CpgRv ð2Þ
where C is the number of magnetic microbeads in the
center part of the chain (40 for a 80-magetic microbead
pearl-like chain trapped in a 40 lm enlarged microchannel
section), g the liquid viscosity and v the velocity of the
liquid with respect to the magnetic microbeads. Figure 2b
presents the magnetic dipolar energy Echain for a chain of
80 microbeads calculated using Eq. 1, as a function of X.
The magnetic energy of the chain increases with X, as the
individual microbead center-to-center distances increase.
This energy variation leads to a magnetic dipolar force
given by
Fchain ¼  oEchainoX : ð3Þ
Figure 2c presents the variation of the magnetic dipolar
force Fchain as a function of X calculated using Eq. 3. A
maximum force of *270 pN is calculated for a distance
X = 250 nm. When the drag force is superior to the mag-
netic force (Fdrag [ Fchain), the central part of the magnetic
chain is no longer retained and the chain breaks in three
parts. Equalizing Fdrag and Fchain lead to a critical mean
fluid velocity for chain rupture of vc = 1.4 mm/s. During
our experiment, we typically use a maximum flow velocity
at the microchannel center of 160 lm/s (i.e., a flow rate of
0.034 nL/s). Then, no chain breaking is observed during
experiments, and the self-assembled magnetic chains stay
retained and are accurately positioned at the entire cross-
section of microchannel.
4 Experimental
All c-Ab and d-Ab solutions are prepared by diluting the
desired amount of Ab in phosphate buffer saline–bovine
serum albumine (PBS–BSA) solution. (PBS–BSA) solution
is prepared by diluting 1% (w/w) BSA (obtained from
Sigma-Aldrich, product no. A7030) in PBS (obtained from
Sigma-Aldrich, product no. P5493) solution (pH 7.4). In
this study, all Ab used are immunoglobulin G (IgG). The
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Fig. 2 a Schematic layout of the microchannel with periodically
varying channel width. In a magnetic field H, the magnetic
microbeads self-assemble into chains that stay trapped in the large
cross-sections. When a fluid flow is applied, the viscous drag force
displaces the center part of the microbead chains. ri,j is the distance
between the nanoparticles with index i and j, respectively. b Magnetic
dipolar energy Echain of a chain consisting of 80 magnetic microbeads
as a function of the displacement X induced by the flow. c Magnetic
retention force Fchain of a chain consisting of 80 microbeads as a
function of X
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c-Ab molecules used for both on- and off-chip immuno-
assay are rabbit biotinylated anti-mouse IgG (obtained
from Dako, product no. E0354). The direct detection Ab
(dd-Ab) molecules used for performing a controlling direct
immunoassay are Cy3-conjugated polyclonal goat anti-
rabbit IgG (obtained from Bioconcept, product no. 601-
104-122). The sandwich detection Ab (sd-Ab) molecules
used for the sandwich immunoassay are Cy3-conjugated
polyclonal goat anti-mouse IgG (obtained from BioCon-
cept, product no. 610-104-121). The t-mAb molecules used
for the sandwich immunoassay are normal mouse IgG
(obtained from Invitrogen, product no. 10400C). The t-mAb
solutions are prepared by diluting 39 lg/mL initial
concentrated solution in cell culture medium (obtained
from Invitrogen) supplemented with 5% fetal calf serum
(FCS, obtained from Invitrogen). Streptavidin coated
magnetic microbeads (MasterBeads Streptavidin obtained
from Ademtech, product no. 03153) are used as magnetic
microbeads for both the on- and off-chip immunoassay.
Immobilization Buffer (obtained from Ademtech, product
number no. 10301) is used as washing buffer (WB),
according to the supplier’s recommendations. For both
protocols, before introducing magnetic microbeads in the
microchannel, we first pour a surface-blocking solution
through the microchip to avoid aspecific Ab adsorption on
the glass channel wall and on the PDMS cover. A volume
of 15 lL of PBS–BSA solution is introduced in one res-
ervoir (reservoir A), after which the solution fills the entire
microchannel by capillary forces within a few seconds.
Then, the second reservoir (reservoir B) is also filled with
15 lL of PBS–BSA solution. After 5 min, both reservoirs
are emptied by withdrawing solutions using a micropipette,
and rinsed with 15 lL of WB.
The ‘off-chip incubation–on-chip detection’ protocol is
illustrated in Fig. 3. In a first step, 10 lL of magnetic
microbead solution is resuspended in 10 lL of WB, to
avoid magnetic beads’ clustering or reaction vial surface
adsorption before c-Ab incubation. The magnetic micro-
beads are then incubated for 30 min under gentle agitation
with 166 lL of c-Ab diluted at 455 ng/mL (Fig. 3i). Using
this c-Ab solution concentration, the size of magnetic
microbead agglomerates formed because of the link between
the surface streptavidin molecules and the c-Ab is limited,
allowing the functionalized magnetic microbeads to be
easily introduced in microchannel. Then, the magnetic
microbeads are washed with 500 lL of WB and resus-
pended in 10 lL of WB. In a second step, the microbeads
are incubated with 500 lL of t-mAb solution (Fig. 3ii) at
different concentrations (from 50 to 200 ng/mL) for
60 min under gentle agitation. Then, the microbeads are
washed with 500 lL of WB and resuspended in 10 lL of
WB, avoiding further magnetic bead adsorption to the
microchannel surface. The final magnetic microbead con-
centration is of 10 mg/mL (Fig. 3iii). A volume of 2 lL of
the magnetic microbead solution is introduced in reservoir
A and flushed into the microchannel by applying a short
over-pressure in the reservoir. Then, the microchip is
placed on its holder supporting the permanent magnets. All
magnetic chains are self-assembled after *10 s (Fig. 3iv).
The magnetic microbead solution remaining in reservoir A
is withdrawn from the microchip with a micropipette, and
reservoir A is filled with 4 lL of PBS-BSA solution. To
execute the on-chip detection, we fill reservoir B with
15 lL of sd-Ab solution at 5 lg/mL (Fig. 3v). The liquid
volume difference between reservoirs A and B provides the
pressure to generate a liquid flow velocity of 160 lm/s at
Wash and 
resuspend
Wash and 
resuspend
c-Ab incubation t-mAb incubation
Beads insertion on chip
Chains formation
sd-Ab applied 
on-chip
(i) (ii) (iii) Washing and 
Fluorescence 
detection
(iv)
(v)
(vi)
c-Ab t-mAb sd-Ab
Fig. 3 Illustration of the ‘off-chip incubation–on-chip detection’
protocol. i The magnetic microbead solution is incubated with
capture antibodies (c-Ab). ii The microbeads are incubated with
target monoclonal antibodies (t-mAb) solution at different concen-
trations under gentle agitation. iii The magnetic microbeads are
introduced in the microchip, where (iv) the magnetic chains self-
assemble. v Flow of the sandwich detection antibodies (sd-Ab)
solution through the magnetic chains. vi After a washing step, the
fluorescence of the chains can be detected
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the microchannel center (Shui et al. 2007), without the
need of external complex tubing or pumping system. The
sd-Ab solution is flown through the microchannel for
7.5 min, to ensure an excess amount of d-Ab with respect
to the t-mAb. Then, reservoir B is rapidly rinsed (with
WB), before application during 3 min of WB through the
microchannel by filling reservoir B with 15 lL of WB
solution. Finally, reservoir B is filled with 15 lL of PBS–
BSA solution during fluorescence detection (Fig. 3vi).
The full on-chip immunoassay protocol has been
previously described in detail (Lacharme et al. 2008a, b).
Briefly, 2 lL of 10 mg/mL magnetic microbead solution
(resuspended in WB to avoid magnetic beads adsorption to
the microchannel wall surface) is introduced in reservoir A
(before c-Ab coating), and flushed into the microchannel
by applying a short over-pressure in reservoir A. The
microchip is placed on its holder containing the permanent
magnets and chains form. Excess of magnetic microbead
solution is withdrawn from reservoir A using a micropi-
pette and replaced by 4 lL of PBS-BSA solution. All other
fluid operations are performed by filling and withdrawing
15 lL of different solutions from reservoir B. The on-chip
direct control immunoassay is performed by subsequently
letting flow through the microchannel (from reservoir B to
reservoir A) solutions of (1) c-Ab at 5 lg/mL for 3 min and
(2) dd-Ab at 5 lg/mL for 5 min. The sandwich immuno-
assay is performed by subsequently letting flow through the
microchannel (from reservoir B to reservoir A) solutions of
(1) c-Ab at 5 lg/mL (in PBS only solution) for 3 min, (2)
t-mAb solutions at different concentrations (from 1 to
200 ng/mL) for 15 min and (3) sd-Ab at 5 lg/mL for
5 min. All steps (during both the direct and sandwich
immunoassay) are separated by a fast-rinsing (*10 s) and
3 min washing step using 15 lL of WB solution introduced
in reservoir B. Finally, the reservoir B is filled with 15 lL
of PBS–BSA solution during fluorescence detection.
Table 1 summarizes the experimental parameters (total
number of magnetic microbeads used, Ab solution volume
and Ab concentration, total number of Ab molecules and
average number of Ab molecules per bead) used for the
three experimental protocols.
For visualization, image acquisition, and fluorescence
detection, we use a CCD camera ORCA-C4742-95ER
(Hamamatsu) mounted on an inverted microscope Axiovert
S100 (Zeiss), with a 1009 objective (LD EC Epiplan-
Neofluar, numerical aperture 0.75), a 409 objective (LD
Achroplan, numerical aperture 0.5) and a 109 objective
(Epiplan, numerical aperture 0.2). The microscope is
equipped with a Mercury short arc lamp HBO (Osram) and
the appropriate filter set for Cy3 dye (filter set no. 20,
Zeiss). The excitation, dichroic mirror, and emission
wavelengths for this filter set are 446–512, 560 and 575–
640 nm, respectively. The exposure time is 2 s and
AquaCosmos software (Hamamatsu) is used for the fluo-
rescence image analysis and for correcting the data for
the background detection signal. Typically, an area of
170 9 20 lm2 with nine consecutive magnetic chains is
analyzed for the immunoassay experiments.
5 Results and discussion
Figure 4a shows an optical image (taken with the 1009
objective) of five self-assembled magnetic chains before
c-Ab coating. During experiments, the magnetic micro-
beads first assemble in primary linear chains in the narrow
and wide sections of the microchannel before constituting
40-lm-long magnetic chains that stay trapped in the
40-lm-large section of the microchannel. Thereby, the
chains are more complex than a pearl-like chain. We
Table 1 Summary of the experimental parameters used for the three experimental protocols
Experimental step Total number
of beads
Ab solution
volume (nL)
Ab solution
concentration
(ng/mL)
Total number of Ab
molecules
Average number of Ab
molecules per bead
Off-chip incubation–on-chip detection
Incubation of c-Ab (off-chip) 7.63 9 108 166 9 103 455 3.02 9 1011 396
Incubation of t-Ag (off-chip) 7.63 9 108 500 9 103 From 50 to 200 From 1 9 1011 to 6 9 1011 From 131 to 786
Application of sd-Ab (on-chip) 29,000 15.3 5,000 3.24 9 108 11,066
Full on-chip direct immunoassay
Application of c-Ab 29,000 6.12 5,000 1.22 9 108 4,167
Application of dd-Ab 29,000 10.2 5,000 2.04 9 108 6,967
Full on-chip sandwich immunoassay
Application of c-Ab 29,000 6.12 5,000 1.22 9 108 4,167
Application of t-mAb 29,000 30.6 From 1 to 200 From 1.22 9 104 to 2.45 9 106 From 4 to 836
Application of sd-Ab 29,000 10.2 5,000 3.24 9 108 11,066
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observe in Fig. 4a linear chains of *1.5 lm diameter with
local small imperfections. To estimate the number of
magnetic microbeads constituting a chain, we calculate the
number of magnetic microbeads initially present in one
trapping unit of the microchannel (a volume of
3.2 9 10-9 mL consisting of one large and one narrow
section of the microchannel). With an initial magnetic mi-
crobead concentration of 10 mg/mL, we conclude that a
single magnetic chain is constituted of approximately 240
magnetic microbeads. Figure 4b shows a fluorescence
microscopy image of *30 chains in the microchannel
obtained after completion of the full on-chip direct control
immunoassay. The two-Ab fluorescent immunocomplexes
(supramolecules constituted by c-Ab and dd-Ab) are clearly
located at the surface of the chains, indicating the high
capture efficiency of the magnetic microbeads in our sys-
tem. Figure 4c shows the fluorescence intensity along the
microchannel axis due to the binding of the two-Ab fluo-
rescent immunocomplexes on magnetic microbeads, as
derived from images like that shown in Fig. 4b. Each peak
corresponds to a single fluorescent magnetic chain. In this
direct control immunoassay, all chains that are periodically
trapped over the 2-mm-long microchannel (representing a
total number of 120 chains) show strong fluorescence
intensity. The large number of c-Ab linked to the surface of
the magnetic microbeads are equivalently distributed over
the 240 microbeads per chain 9 120 (chains) % 29,000
magnetic microbeads in the microchannel. During flowing
of the c-Ab solution, 1.22 9 108 c-Ab molecules are
introduced in the microchannel. On average, 4,167 c-Ab are
linked at the surface of each microbead in the microchannel,
and this by only consuming 6.12 nL of c-Ab solution.
Figure 5a shows an optical microscopy image of the
self-assembled magnetic chains in the microchannel after
off-chip c-Ab and t-mAb incubation. The chains are
accurately positioned in the geometrical traps. However,
their size and homogeneity present slight variations, due to
the off-chip incubation protocol. Indeed, when off-chip
incubated, the magnetic microbeads are linked by c-Ab and
form small microbead clusters. Once introduced in the mi-
crochannel, the clusters are embedded in the self-assembled
magnetic chains during their formation and create chain
irregularities. Figure 5b shows a fluorescence image of the
self-assembled magnetic chains in the microchannel after
completion of the ‘off-chip incubation–on-chip detection’
Fig. 4 a Optical image of five self-assembled magnetic chains.
b Fluorescence microscopic image of 30 consecutive self-assembled
magnetic microbead chains after the realization of the direct control
immunoassay. c Fluorescence intensity along the microchannel axis
due to the formation of the two-Ab fluorescent immunocomplexes on
the magnetic microbeads, as derived from images like shown in b
Fig. 5 a Optical image of the self-assembled magnetic chains after
the off-chip c-Ab and t-mAb incubation. b Fluorescence image of the
self-assembled magnetic chains in the microchannel after completion
of the ‘off-chip incubation–on-chip detection’ sandwich immunoas-
say. c Fluorescence image obtained after completion of the full on-
chip sandwich immunoassay
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sandwich immunoassay. The three-Ab fluorescent immu-
nocomplexes (supramolecules constituted by c-Ab, t-mAb
and sd-Ab) are clearly located on the magnetic chains. The
fluorescence signal presents variations along the chain axis
due to the chain irregularities. This phenomenon is not
observed in the full on-chip sandwich immunoassay (where
we introduce the magnetic microbeads in the microchannel
before c-Ab coating), because the microbeads behave as
independent particles which self-assemble only due to
magnetic interactions when exposed to the external magnetic
field. For comparison, Fig. 5c shows a fluorescence image
obtained after completion of the full on-chip sandwich
immunoassay. The chains are accurately positioned in the
geometrical traps and are regular in size, while the fluores-
cent signal is homogeneous along the chain axis.
Figure 6a shows the fluorescence intensity of nine
magnetic chains along a section of the microchannel, as
derived from an image like shown in Fig. 5b, after com-
pletion of the ‘off-chip incubation–on-chip detection’
immunoassay. In a sandwich immunoassay, the limiting
factor for the three-Ab immunocomplex formation is the
number of t-mAb. During the off-chip incubation, c-Ab and
t-mAb are homogeneously distributed over the magnetic
microbead surface. The total fluorescence signal averages
out chain-to-chain intensity fluctuation. The integration
over all fluorescent chains on the image is proportional to
the total number of t-mAb captured on the magnetic
microbeads. Figure 6b shows the total integrated fluores-
cence as a function of the t-mAb concentration, obtained
from curves like shown in Fig. 6a. Although the average
number of c-Ab per magnetic microbead is lower than the
average number of t-mAb per bead for solution concen-
trations above 150 ng/mL (see Table 1), the signal
increases linearly for t-mAb concentrations between 50 and
200 ng/nL. This indicates that a portion of t-mAb mole-
cules are probably not captured, when incubated off-chip.
The ‘off-chip incubation–on-chip detection’ protocol is
also applied to 500 lL of the supernatant of a cell culture
to measure the t-mAb concentration in a non-purified
sample solution. The cell culture is prepared by conven-
tional hybridoma technology (Plessers et al. 1990) in a
conditioned cell culture medium to produce t-mAb (5D10
a b
c d
Fig. 6 a Fluorescence intensity along a section of the microchannel
after completion of the ‘off-chip incubation–on-chip detection’
sandwich immunoassay. b Total fluorescence as a function of the
t-mAb concentration for the ‘off-chip incubation–on-chip detection’
sandwich immunoassay. c Fluorescence intensity along the
microchannel after the completion of the full on-chip sandwich
immunoassay. d Total fluorescence as a function of the t-mAb
concentration for the full on-chip sandwich immunoassay
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Ab directed against the human breast cancer cell line
MCF-7). Using the total fluorescence response curve of
Fig. 6b, we find a concentration of 113 ± 7 ng/mL. For
comparison, this concentration is measured to be*125 ng/
mL by a classical ELISA test (in a total assay time of 3.5 h).
Figure 6c shows the fluorescence intensity of the first 16
chains along the microchannel after the completion of the
full on-chip sandwich immunoassay, as derived from
images like the one shown in Fig. 5c. The chains that are
more upstream positioned in the microchannel show the
highest fluorescence intensity, which is an indication of the
high capture efficiency. Integrating overall fluorescent
chains on the complete microchannel provides the total
number of t-mAb captured by all chains. Figure 6d shows
the total fluorescence intensity as a function of the t-mAb
concentration, obtained from curves like the one shown in
Fig. 6c. As expected, the signal increases with the t-mAb
concentration.
It is clear from Fig. 6c that, during the full on-chip
sandwich immunoassay, the magnetic chains gradually
deplete the t-mAb concentration downstream of the flow.
Consequently, the t-mAb molecules are not homoge-
neously distributed over all chains. In the absence of Ab
saturation effects on the microbeads, the t-mAb concen-
tration, exposing the Nth chain in the microchannel and
proportional to its fluorescence intensity, can be written as
CN ¼ C0  ð1  PÞN ð4Þ
where C0 is the initial concentration of t-mAb and P (\1)
the capture probability of the chains. Figure 7 presents the
experimental maximal fluorescent intensity extracted from
Fig. 6c for chains # 1–15. As predicted by Eq. 4, the
maximal fluorescent intensity follows an exponential
decrease as a function of the chain number. The
experimental capture probability of a chain can be
extracted from experimental data by plotting on a single
log scale the maximal fluorescent intensity versus chain
number (see insert of Fig. 7).
log
CN
C0
 
¼ N logð1  PÞ ð5Þ
For our flow condition (flow rate of 0.034 nL/s), the
experimental capture probability of a chain determined
using Eq. 5 is found to be P = 0.29 (i.e., 29% of all t-mAb
reaching a microchannel elementary volume, in which one
chain is located, will be captured, while the rest continues
to advance through the microchannel and will be captured
by further chains). Both reaction kinetics and diffusion
effects have an influence on the capture probability. Due to
diffusion, a minimum number of chains are needed to
capture all t-mAb from the flow, even for instantaneous
immunoreactions at the microbead surface. Diffusing over
a distance corresponding to half of the microchannel height
h/2 = 4 lm, with a diffusion coefficient for t-mAb of
D = 40 9 10-8 cm2/s, typically takes h2/(4D) & 0.4 s.
Using an average flow speed of 100 lm/s, we find that, at
minimum, the flow needs to pass over a length of 40 lm
before all t-mAb molecules have diffused to a magnetic
chain. This corresponds to a minimum number of three
chains that will show fluorescence, in qualitative agreement
with the experimental results. When the flow rate decreases
down to a flow velocity of 37 lm/s, the time allowed for a
t-mAb molecule to diffuse to the chain surface will
increase, and only two chains would be sufficient to capture
all t-mAb. Decreasing further the flow rate down to a value
below the typical diffusion speed (10 lm/s) will result in
the capture of all t-mAb by the first chain of the system.
6 Conclusion
We have demonstrated two protocols to perform on-chip
sandwich immunoassays, using magnetic microbeads that
are self-assembled in magnetic chains as reaction substrate.
When incubated off-chip, t-mAb are distributed over all the
magnetic microbead surfaces, and the fluorescence signal
obtained reaches a similar level for all chains in the
microchannel. This protocol demonstrates the extension of
the use of our magnetic microbead retention device to
applications involving off-chip immunoreactions with
magnetic microbeads. When the t-mAb molecules are
captured from a flow in the microchannel, the magnetic
chains gradually deplete the t-mAb concentration down-
stream of the flow, and the t-mAb molecules are unequally
Fig. 7 Experimental maximal fluorescent intensity extracted from
Fig. 6c for chains # 1–15. The maximal fluorescent intensity follows
an exponential decrease as a function of the chain number. The insert
shows a single log scale plot of the maximal fluorescent intensity
versus chain number for chains # 1–9 (full on-chip sandwich
immunoassay)
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distributed on all chains. From the spatial dependence of the
fluorescence intensity, we calculate a magnetic chain cap-
ture probability of 29%, primarily due to the finite diffusion
times needed for the t-mAb to reach a magnetic chain. In the
‘off-chip incubation–on-chip detection’ protocol, antibod-
ies can be detected down to a concentration of 50 ng/mL in
a total assay time of 120 min, while consuming 1.5 mL of
target antibody solution. Using the full on-chip protocol,
our system is able to detect target antibodies down to a few
ng/mL in 30 min, and using only a few tens of nanoliters of
target antibody solution and reagents. Our work shows
that positioning magnetic microbeads in chains across a
microchannel results in a very strong particle-liquid inter-
action and strongly enhances the fluid perfusion through
the magnetic structures. Our results suggest a high potential
for immunoassays performed on-chip in our simple and
versatile system, consuming lower reagent volumes and
strongly reducing experimental time and costs. Moreover,
we presume that the principle of magnetic chains’ retention
in a microfluidic flow, and incubation of the magnetic beads
with analytes, either off- or on-chip, can equally well be
used for other bio-analytical or catalytic applications.
References
Andersson H, van der Wijngaart W et al (2000) Micromachined flow-
through filter-chamber for chemical reactions on beads. Sens
Actuators B Chem 67(1–2):203–208
Bronzeau S, Pamme N (2008) Simultaneous bioassays in a micro-
fluidic channel on plugs of different magnetic particles. Anal
Chim Acta 609(1):105–112
Choi JW, Oh KW et al (2002) An integrated microfluidic biochemical
detection system for protein analysis with magnetic bead-based
sampling capabilities. Lab Chip 2(1):27–30
Deng T, Prentiss M et al (2002) Fabrication of magnetic micro-
filtration systems using soft lithography. Appl Phys Lett
80(3):461–463
Doyle PS, Bibette J et al (2002) Self-assembled magnetic matrices for
DNA separation chips. Science 295(5563):2237
Gijs MAM (2004) Magnetic bead handling on-chip: new opportuni-
ties for analytical applications. Microfluidics Nanofluidics
1(1):22–40
Hayes MA, Polson NA et al (2001) Flow-based microimmunoassay.
Anal Chem 73(24):5896–5902
Helseth LE (2005) Self-assembly of colloidal pyramids in magnetic
fields. Langmuir 21(16):7276–7279
Herrmann M, Veres T et al (2006) Enzymatically-generated fluores-
cent detection in micro-channels with internal magnetic mixing
for the development of parallel microfluidic ELISA. Lab Chip
6(4):555–560
Herrmann M, Roy et al (2007) Microfluidic ELISA on non-passivated
PDMS chip using magnetic bead transfer inside dual networks of
channels. Lab Chip 7(11)1546–1552
Lacharme F, Vandevyver C et al (2008a) Magnetic beads retention
device for on-chip sandwich immuno-assay. In: Mems 2008:
21st IEEE international conference on micro electro mechanical
systems, technical digest, pp 184–187
Lacharme F, Vandevyver C et al (2008b) Full on-chip nanoliter
immunoassay by geometrical magnetic trapping of nanoparticle
chains. Anal Chem 80(8):2905–2910
Lund-Olesen T, Bruus H et al (2007) Quantitative characterization of
magnetic separators: comparison of systems with and without
integrated microfluidic mixers. Biomed Microdevices 9(2):195–
205
Manz A, Graber N et al (1990) Miniaturized total chemical-analysis
systems—a novel concept for chemical sensing. Sens Actuators
A 10(1–6):244–248
Pavius M, Hibert C et al (2004) Profile angle control in SIO2 deep
anisotropic dry etching for MEMS fabrication. In: Mems 2004:
17th IEEE international conference on micro electro mechanical
systems, technical digest, pp 669–672
Peyman SA, Lies A et al (2008) Rapid on-chip multi-step (bio)chem-
ical procedures in continuous flow—manoeuvring particles
through co-laminar reagent streams. Chem Commun 10:1220–
1222
Plessers L, Bosmans E et al (1990) Production and immunohisto-
chemical reactivity of mouse antiepithelial monoclonal-
antibodies raised against human breast-cancer cells. Anticancer
Res 10(1):271–277
Rida A, Gijs MAM (2004) Manipulation of self-assembled structures
of magnetic beads for microfluidic mixing and assaying. Anal
Chem 76(21):6239–6246
Rida A, Fernandez V et al (2003) Long-range transport of magnetic
microbeads using simple planar coils placed in a uniform
magnetostatic field. Appl Phys Lett 83(12):2396–2398
Sato K, Tokeshi M et al (2001) Determination of carcinoembryonic
antigen in human sera by integrated bead bed immunoasay in a
microchip for cancer diagnosis. Anal Chem 73(6):1213–1218
Shui LL, Eijkel JCT et al (2007) Multiphase flow in micro- and
nanochannels. Sens Actuators B Chem 121(1):263–276
Siegel AC, Shevkoplyas SS et al (2006) Cofabrication of electro-
magnets and microfluldic systems in poly(dimethylsiloxane).
Angew Chem Int Ed 45(41):6877–6882
Slovakova M, Minc N et al (2005) Use of self assembled magnetic
beads for on-chip protein digestion. Lab Chip 5(9):935–942
Smistrup K, Kjeldsen BG et al (2005) On-chip magnetic bead
microarray using hydrodynamic focusing in a passive magnetic
separator. Lab Chip 5(11):1315–1319
Microfluid Nanofluid (2009) 7:479–487 487
123
